Cardiac embolism refers to a condition where a blood clot, or embolus, travels from another part of the body and lodges in the heart's blood vessels, disrupting normal blood flow. This phenomenon poses a significant risk, as it can lead to serious complications, including strokes or heart attacks. The embolus typically originates in the arteries or chambers of the heart itself or may travel from other parts of the body, such as the legs, where deep vein thrombosis can occur. Prevention and management of cardiac embolism often involve anticoagulant medications to reduce the risk of blood clot formation. Understanding the underlying causes and risk factors, along with timely medical intervention, plays a crucial role in addressing and mitigating the impact of cardiac embolism on cardiovascular health.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation